Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts, Ian Bruce, University of Manchester, UK, and Julia Weinmann-Menke, Johannes Gutenberg University Mainz, Germany, discuss the latest SLE Treatment Recommendations from the European League Against Rheumatism (EULAR), which detail advanced management and targeting remission as elevated treatment goals to improve patient outcomes.
In this issue
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given